The key challenges due to COVID-19 pandemic restrictions for Iranian T1DM patients were the need to take more insulin, lower physical activity, increased BMI, non-availability of insulin, and missed morning insulin dose. This evidence concerns the gene INS and type 1 diabetes mellitus.